← All indications
Helicobacter Infections
Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
Drugs by status
Approved for this indication (4)
Phase 4 trials (20)
Phase 3 trials (6)
Phase 2 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (27)
- Il-Yang Pharm. Co., Ltd.
- Pacific Pharmaceuticals
- Baylor University
- Clinical Centre of Serbia
- Inje University
- Kaohsiung Medical University
- Mahidol University
- Seoul National University
- Zagazig University
- Ilam University of Medical Sciences
- Taichung Veterans General Hospital
- University of Ulsan
- Zhejiang University
- Shandong University
- University of Indonesia
- Jiao Tong University
- Government of Mexico
- American University of Beirut
- National Taiwan University
- University of Ljubljana
- Government of Korea
- Catholic University of Korea
- University of Valladolid
- Johnson and Johnson
- Dongguk University
- Government of Taiwan
- Mackay Medical College
Organization Involved with Phase 3 Indications (29)
- Axcan
- Forest Laboratories
- Atlantia Food Clinical Trials
- Michael J. Fox Foundation for Parkinson's Research
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Cairo University
- Hamamatsu University
- Mansoura University
- Tanta University
- Universidad del Valle, Colombia
- University of Regensburg
- University of Bari
- University of Bologna
- Assiut University
- Chonbuk National University
- Tel Aviv University
- University of California, Los Angeles
- Vanderbilt University
- Al Azhar University
- Mercy University
- University of Sao Paulo
- Universidad del Valle de Guatemala
- University of Erlangen-Nuremberg
- Technical University of Dresden
- Sungkyunkwan University
- Yokoyama Foundation for Clinical Pharmacology
- University of Campania Luigi Vanvitelli
- University of North Texas
- Phathom Pharmaceuticals, Inc.
Organization Involved with Phase 2 Indications (2)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (16)
- BioGaia AB
- Otsuka
- Bulent Ecevit University
- Centro Regional para el Estudio de las Enfermedades Digestivas
- Guangzhou Medical University
- Capital Medical University
- Fudan University
- International Center for Diarrheal Disease Research
- Hallym University
- University of Split
- Department of Veteran Affairs
- People's Liberation Army of China
- Krka
- Incheon St.Mary's Hospital
- Institute of Gastroenterology and Hepatology, Vietnam
- Slovenian Society for Gastroenterology and Hepatology